[go: up one dir, main page]

Gandrille et al., 1988 - Google Patents

Association of inherited dysfibrinogenaemia and protein C deficiency in two unrelated families

Gandrille et al., 1988

Document ID
11901577537458154308
Author
Gandrille S
Priollet P
Capron L
Roncato M
Fiessinger J
Aiach M
Publication year
Publication venue
British journal of haematology

External Links

Snippet

An inherited association of dysfibrinogenaemia and protein C deficiency was found in three members of the same family. The propositus was a 48‐year‐old man who suffered from severe and rapidly complicated atherosclerosis of the aorta and lower limbs arteries, which …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis

Similar Documents

Publication Publication Date Title
Soria et al. A new type of congenital dysfibrinogenaemia with defective fibrin lysis—Dusard syndrome: possible relation to thrombosis
Nilsson et al. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
Bauer et al. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation
Marlar et al. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation
Kinoshita et al. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura
Griffin et al. Deficiency of protein C in congenital thrombotic disease.
Schlegel Thromboembolic risks and complications in nephrotic children
AU596951B2 (en) Blood coagulation inhibiting proteins, processes for preparing them and their uses
JP4176157B2 (en) Determination of coagulation parameters
EP0952215A2 (en) Protease for activating clotting factor VII
JP4361980B2 (en) Method for measuring the potential anticoagulant potential of a sample
Suomela et al. The activation of factor X evaluated by using synthetic substrates
Haverkate et al. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis
Réganon et al. Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction
Gandrille et al. Association of inherited dysfibrinogenaemia and protein C deficiency in two unrelated families
Fukuda et al. Measuring tissue factor (factor III) activity in plasma.
Pabinger-Fasching et al. High levels of plasma protein C in nephrotic syndrome
Halvorsen et al. Does Lp (a) lipoprotein inhibit the fibrinolytic system?
Hedner et al. Inhibition of activated haceman factor (factor XIIa) by an inhibitor of the plasminogen activation (PA inhibitor)
Aiach et al. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer
Nilsson Coagulation and fibrinolysis
Dryjski et al. Effect of glycosaminoglycans and antithrombin III on uptake and inhibition of thrombin by the vascular wall
Girolami et al. Chromogenic Substrate (S-2238) Prothrombin Assay in Prothrombin Deficiencies and Abnormalities. Lack of Identity with Clotting Assays in Congenital Dysprothrombinemias.
Higgins et al. Fibrinogen Petoskey: Identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A
JP3127263B2 (en) Part VIII: Ca factor chromogen assay